We are live on ! Find out more
CAH icon

Cardinal Health

808 hedge funds and large institutions have $21.7B invested in Cardinal Health in 2016 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 314 increasing their positions, 302 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 59

2% more funds holding

Funds holding: 794808 (+14)

4% more repeat investments, than reductions

Existing positions increased: 314 | Existing positions reduced: 302

4% more call options, than puts

Call options by funds: $60.4M | Put options by funds: $58.2M

0.94% more ownership

Funds ownership: 84.41%85.35% (+0.94%)

5% less capital invested

Capital invested by funds: $22.8B → $21.7B (-$1.09B)

7% less funds holding in top 10

Funds holding in top 10: 1413 (-1)

Holders
808
Holders Change
+14
Holders Change %
+1.76%
% of All Funds
21.51%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.35%
New
83
Increased
314
Reduced
302
Closed
59
Calls
$60.4M
Puts
$58.2M
Net Calls
+$2.19M
Net Calls Change
+$12.2M

CAH Hedge Fund Activity: Q2 2016 in Review

808 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q2 2016, worth a combined $21.7B — down 4.8% from $22.8B a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new CAH positions and 59 closed out — a net gain of 24 holders — while 314 added to existing stakes and 302 trimmed.

The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $533M. The largest seller was Ameriprise, cutting an estimated $272M.

  • 808 institutional investors held Cardinal Health (CAH) as of Q2 2016, up from 794 in Q1 2016.
  • Funds reported $21.7B of Cardinal Health stock for Q2 2016, down 4.8% quarter-over-quarter.
  • 83 funds opened new Cardinal Health positions in Q2 2016 and 59 closed out, a net change of +24 holders.
  • The largest Cardinal Health buyer in Q2 2016 was Barrow, Hanley, Mewhinney & Strauss, an estimated $533M added.
  • The largest Cardinal Health seller in Q2 2016 was Ameriprise, an estimated $272M sold.

Based on aggregated 13F filings for Q2 2016.